Sino Biopharmaceutical | 1177 - Gross Profit On Sales

Stock Price
6.04
Daily Change
-0.29 -4.58%
Monthly
-2.11%
Yearly
77.65%
Q2 Forecast
6.08

Sino Biopharmaceutical reported CNY10.5B in Gross Profit on Sales for its fiscal semester ending in December of 2024.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Jiangsu Hengrui CNY 6.36B 1.15B Sep/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025